MYC and ovarian cancer: The group demonstrated that therapeutic siRNA-mediated silencing of c-Myc resulted in a significant reduction in tumor growth and induction of cell cycle arrest and apoptosis in ovarian cancer cell lines and murine xenograft models [45].